Literature DB >> 10818527

Cortical cholinergic denervation elicits vascular A beta deposition.

A E Roher1, Y M Kuo, P E Potter, M R Emmerling, R A Durham, D G Walker, L I Sue, W G Honer, T G Beach.   

Abstract

Selective destruction of the cholinergic nucleus basalis magnocellularis (nbm) in the rabbit by the p75 neurotrophin receptor (NTR) immunoglobulin G (IgG) complexed to the toxin saporin leads to the deposition of amyloid-beta (A beta) in and around cerebral blood vessels. In some instances, the perivascular A beta resemble the diffuse deposits observed in Alzheimer's disease (AD). We propose that cortical cholinergic deprivation results, among other perturbations, in the loss of vasodilation mediated by acetylcholine. In addition to a dysfunctional cerebral blood flow, alterations in vascular chemistry affecting endothelial and smooth muscle cells may result in cerebral hypoperfusion and a breached blood-brain barrier (BBB). The selective removal of the rabbit nbm and A beta accumulation may serve as an important nontransgenic, and more physiological, model for the testing of pharmacological and immunological agents designed to control the deposition and the deleterious effects of A beta in AD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818527     DOI: 10.1111/j.1749-6632.2000.tb06388.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission.

Authors:  Saak V Ovsepian; Valerie B O'Leary; Laszlo Zaborszky
Journal:  Neuroscientist       Date:  2015-05-22       Impact factor: 7.519

2.  Neurovascular changes measured by time-of-flight MR angiography in cholesterol-fed rabbits with cortical amyloid beta-peptide accumulation.

Authors:  Susan K Lemieux; Carrie A Smith-Bell; Jered R Wells; Nnadozie M Ezerioha; Jeffrey S Carpenter; D Larry Sparks; Bernard G Schreurs
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

3.  Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study.

Authors:  Shelly L Gray; Melissa L Anderson; Sascha Dublin; Joseph T Hanlon; Rebecca Hubbard; Rod Walker; Onchee Yu; Paul K Crane; Eric B Larson
Journal:  JAMA Intern Med       Date:  2015-03       Impact factor: 21.873

4.  High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease.

Authors:  Virawudh Soontornniyomkij; Cecilia Choi; Justine Pomakian; Harry V Vinters
Journal:  Hum Pathol       Date:  2010-08-04       Impact factor: 3.466

5.  Association of Anticholinergic Drug Use With Risk for Late Age-Related Macular Degeneration.

Authors:  Gauthier Aldebert; Jean-Luc Faillie; Dominique Hillaire-Buys; Thibault Mura; Isabelle Carrière; Cécile Delcourt; Catherine Creuzot-Garcher; Max Villain; Vincent Daien
Journal:  JAMA Ophthalmol       Date:  2018-07-01       Impact factor: 7.389

6.  Cannabinoid Receptors and Glial Response Following a Basal Forebrain Cholinergic Lesion.

Authors:  Alberto Llorente-Ovejero; Iker Bengoetxea de Tena; Jonatan Martínez-Gardeazabal; Marta Moreno-Rodríguez; Laura Lombardero; Iván Manuel; Rafael Rodríguez-Puertas
Journal:  ACS Pharmacol Transl Sci       Date:  2022-08-04

7.  Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice.

Authors:  Juan Jose Ramos-Rodriguez; Mar Pacheco-Herrero; Diana Thyssen; Maria Isabel Murillo-Carretero; Esther Berrocoso; Tara L Spires-Jones; Brian J Bacskai; Monica Garcia-Alloza
Journal:  J Neuropathol Exp Neurol       Date:  2013-04       Impact factor: 3.685

Review 8.  Integrated phylogeny of the human brain and pathobiology of Alzheimer's disease: A unifying hypothesis.

Authors:  Saak V Ovsepian; Valerie B O'Leary; Cyril Hoschl; Laszlo Zaborszky
Journal:  Neurosci Lett       Date:  2021-04-20       Impact factor: 3.197

9.  A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older Adults.

Authors:  Jessica E Lockery; Jonathan C Broder; Joanne Ryan; Ashley C Stewart; Robyn L Woods; Trevor T-J Chong; Geoffrey C Cloud; Anne Murray; Jason D Rigby; Raj Shah; Elsdon Storey; Stephanie A Ward; Rory Wolfe; Christopher M Reid; Taya A Collyer; Michael E Ernst
Journal:  J Gen Intern Med       Date:  2021-03-22       Impact factor: 6.473

10.  Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons.

Authors:  Valentina Latina; Silvia Caioli; Cristina Zona; Maria T Ciotti; Giuseppina Amadoro; Pietro Calissano
Journal:  Front Cell Neurosci       Date:  2017-03-15       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.